Icahn School of Medicine at Mount Sinai
Understands the compounded-drug boundary
Nausea, loss of appetite, or vomiting
Jun 26, 2026 Articles, GLP- 1 Agonist Therapy Center, Obesity, Obesity, Physician oriented, Safety, Therapies 1,669 views As demand for GLP-1 receptor agonists continues to outpace supply, many patients have turned to compounded medications obtained through telehealth companies, medical spas, wellness clinics, and compounding pharmacies
External resources GLP-1 Receptor Agonists: Beyond Glycemic Control (Nature Reviews Endocrinology) Understanding Obesity: Causes, Consequences, and Treatment (The Obesity Society) And if you have made it this far, in case nobody has told you lately, good morning, and in case I do not see you, good afternoon, good evening, and good night
Researchers injected ipamorelin (100ug/kg) three times per day for 3 months in female rats